WO2006026475A3 - Homeopathic compositions and methods for the treatment of cancer - Google Patents

Homeopathic compositions and methods for the treatment of cancer Download PDF

Info

Publication number
WO2006026475A3
WO2006026475A3 PCT/US2005/030492 US2005030492W WO2006026475A3 WO 2006026475 A3 WO2006026475 A3 WO 2006026475A3 US 2005030492 W US2005030492 W US 2005030492W WO 2006026475 A3 WO2006026475 A3 WO 2006026475A3
Authority
WO
WIPO (PCT)
Prior art keywords
homeopathic
compositions
cancer
methods
homeopathic compositions
Prior art date
Application number
PCT/US2005/030492
Other languages
French (fr)
Other versions
WO2006026475A2 (en
Inventor
Wayne B Jonas
Original Assignee
Samueli Inst
Wayne B Jonas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/927,717 external-priority patent/US20060045918A1/en
Priority claimed from US10/928,506 external-priority patent/US20060045919A1/en
Application filed by Samueli Inst, Wayne B Jonas filed Critical Samueli Inst
Publication of WO2006026475A2 publication Critical patent/WO2006026475A2/en
Publication of WO2006026475A3 publication Critical patent/WO2006026475A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/13—Coniferophyta (gymnosperms)
    • A61K36/14—Cupressaceae (Cypress family), e.g. juniper or cypress
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0004—Homeopathy; Vitalisation; Resonance; Dynamisation, e.g. esoteric applications; Oxygenation of blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Provided are homeopathic compositions and methods for the preparation and use of such homeopathic compositions. Therapeutic methods comprise the administration of combinations of homeopathic compositions to provide the effective treatment of cancer, such as prostate cancers. Homeopathic compositions may be prepared by extracting from a patient a tissue sample comprising a tumor cell and a reactive tissue cell that is located in proximity to the tumor cell. Such a tissue sample is suspended in a liquid carrier solution and succussed serially in a liquid carrier solution to provide the homeopathic composition having a homeopathic potency. Homeopathic methods comprise the administration of a homeopathic composition optionally in combination with a second homeopathic composition. Exemplary second homeopathic compositions include Thuja occidentalis, Conium maculaturm, and Sabal serulata.
PCT/US2005/030492 2004-08-27 2005-08-25 Homeopathic compositions and methods for the treatment of cancer WO2006026475A2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US10/927,717 US20060045918A1 (en) 2004-08-27 2004-08-27 Homeopathic compositions and methods for the treatment of cancer
US10/927,717 2004-08-27
US10/928,506 US20060045919A1 (en) 2004-08-27 2004-08-27 Homeopathic compositions and methods for the treatment of cancer
US10/928,506 2004-08-27

Publications (2)

Publication Number Publication Date
WO2006026475A2 WO2006026475A2 (en) 2006-03-09
WO2006026475A3 true WO2006026475A3 (en) 2006-08-17

Family

ID=36000630

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2005/030492 WO2006026475A2 (en) 2004-08-27 2005-08-25 Homeopathic compositions and methods for the treatment of cancer

Country Status (1)

Country Link
WO (1) WO2006026475A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0702089C1 (en) * 2007-03-09 2009-12-29 Roberto Piraino immunomodulatory homeopathic medicine, assist in the treatment of diseases of the immune system
BR112012005562B1 (en) * 2009-09-13 2021-11-16 Valsanic Enterprises Llc PROCESS FOR OBTAINING A HOMEOPATHIC DRUG AND HOMEOPATHIC DRUG

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
JONAS W.B. ET AL.: "A Critical Overview of Homeopathy", ANNUALS OF INTERNAL MEDICINE, vol. 138, 2003, pages 393 - 399, XP002355318 *

Also Published As

Publication number Publication date
WO2006026475A2 (en) 2006-03-09

Similar Documents

Publication Publication Date Title
WO2006023803A3 (en) Methods of administering microparticles combined with autologous body components
MX2011012513A (en) Methods for treating cancer and non-neoplastic conditions.
EP2759302A3 (en) 4F-benzoyl-TN14003 combined with rituximab for use in the treatment of a tumour
BRPI0608175A2 (en) method of eliminating heterogeneous or mixed cell population in tumors as well as maytansinoid compounds
WO2007147128A3 (en) Non-toxic anti-cancer drug combining ascorbate, magnesium and a naphthoquinone
WO2005123908A3 (en) Novel cancer cell lines and uses thereof
WO2011109422A8 (en) Compositions and methods for the treatment of cancer
HK1096023A1 (en) Combination therapy with azd2171 and 5-fu and/or cpt-11 azd2171?5-fu?cpt-11
GB2451196A (en) Compositions and methods for promoting the healing of tissue of multicellular organisms
WO2005065361A3 (en) Compounds and compositions for treating dysproliferative diseases, and methods of use thereof
WO2006016525A3 (en) Genes and polypeptides relating to breast cancers
MXPA05008583A (en) Combination therapy of zd6474 with 5-fu or/and cpt-11.
WO2008142862A1 (en) Anticancer therapy by transplanting vascular endothelial progenitor cells
WO2006026475A3 (en) Homeopathic compositions and methods for the treatment of cancer
IL114382A (en) Lymphotoxin for use as a medicament for cancer therapy and use thereof in the manufacture of such medicament
CN102198198A (en) Tea drink for treating cancer
WO2013133873A3 (en) Pharmaceutical compositions of sodium ion and calcium ion and methods for treating cancer, tumor and non-malignancy
HUP0300923A2 (en) Methods and compositions useful for modulation of angiogenesis using protein kinase raf and ras
WO2006069217A3 (en) Small molecule cyclin d1 ablative agents
HK1124776A1 (en) Treatment of drug-resistant tumors
WO2009041573A1 (en) Use of anti-cancer cell composition for treatment of head and neck cancer, which is intended to be administered to nutrient artery of tumor
WO2008106606A3 (en) Carotenoid analogs and derivatives in the treatment of prostate cancer
RU2009137770A (en) Intravesical administration of apaziquon after transurethral resection in the treatment of cancer
MXPA05013827A (en) Compositions comprising zd6126 together with 5-fu, cpt-11 or 5-fu and cpt-11 having vascular damaging activity for treating e.g. colorectal cancer.
Ren et al. Combined treatment for pain from bone metastases in patients with prostate cancer

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

NENP Non-entry into the national phase

Ref country code: DE

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase